Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
NR4A2 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 1.67E3 | Evidence | |||||
NR4A2 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 1.32E3 | Evidence | |||||
NR4A2 | MAP2K3 | N/A | 255.0 | Evidence | |||||
NR4A2 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 181.0 | Evidence | |||||
NR4A2 | TP53 | TP53, P53: Cellular tumor antigen p53 | 82.10 | Evidence | |||||
NR4A2 | CREBBP | CREBBP, CBP: CREB-binding protein | 56.70 | Evidence | |||||
NR4A2 | JUN | JUN: Transcription factor AP-1 | 26.00 | Evidence | |||||
NR4A2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 20.40 | Evidence | |||||
NR4A2 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 20.40 | Evidence | |||||
NR4A2 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 18.10 | Evidence | |||||
NR4A2 | JUND | JUND: Transcription factor jun-D | 16.50 | Evidence | |||||
NR4A2 | GCN5L2 | GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 | 13.60 | Evidence | |||||
NR4A2 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 12.90 | Evidence | |||||
NR4A2 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 10.30 | Evidence | |||||
NR4A2 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 10.30 | Evidence | |||||
NR4A2 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 8.22 | Evidence | |||||
NR4A2 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 7.43 | Evidence | |||||
NR4A2 | NR2F1 | NR2F1, EAR3, ERBAL3, TFCOUP1: COUP transcription factor 1 | 6.54 | Evidence | |||||
NR4A2 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 6.45 | Evidence | |||||
NR4A2 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 6.24 | Evidence | |||||
NR4A2 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 6.16 | Evidence | |||||
NR4A2 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 5.87 | Evidence | |||||
NR4A2 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 5.86 | Evidence | |||||
NR4A2 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 5.86 | Evidence | |||||
NR4A2 | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 5.86 | Evidence | |||||
NR4A2 | PSMC1 | PSMC1: 26S protease regulatory subunit 4 | 5.27 | Evidence | |||||
NR4A2 | CDC23 | CDC23: Cell division cycle protein 23 homolog | 5.27 | Evidence | |||||
NR4A2 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 4.78 | Evidence | |||||
NR4A2 | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 4.63 | Evidence | |||||
NR4A2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 4.58 | Evidence | |||||
NR4A2 | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 4.01 | Evidence | |||||
NR4A2 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 3.88 | Evidence | |||||
NR4A2 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 3.47 | Evidence | |||||
NR4A2 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 3.47 | Evidence | |||||
NR4A2 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 3.45 | Evidence | |||||
NR4A2 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 3.45 | Evidence | |||||
NR4A2 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 3.34 | Evidence | |||||
NR4A2 | RAB4A | N/A | 3.34 | Evidence | |||||
NR4A2 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 3.07 | Evidence | |||||
NR4A2 | IRS1 | IRS1: Insulin receptor substrate 1 | 3.07 | Evidence | |||||
NR4A2 | TOP2B | N/A | 3.07 | Evidence | |||||
NR4A2 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 3.07 | Evidence | |||||
NR4A2 | PSMC5 | PSMC5, SUG1: 26S protease regulatory subunit 8 | 3.01 | Evidence | |||||
NR4A2 | PRKAA2 | PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 2.99 | Evidence | |||||
NR4A2 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 2.99 | Evidence | |||||
NR4A2 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 2.99 | Evidence | |||||
NR4A2 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 2.75 | Evidence | |||||
NR4A2 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 2.75 | Evidence | |||||
NR4A2 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 2.49 | Evidence | |||||
NR4A2 | THRA | THRA, ERBA1, NR1A1, THRA1, THRA2: Thyroid hormone receptor alpha | 2.43 | Evidence | |||||
NR4A2 | SYK | SYK: Tyrosine-protein kinase SYK | 2.33 | Evidence | |||||
NR4A2 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 2.28 | Evidence | |||||
NR4A2 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 2.23 | Evidence | |||||
NR4A2 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 2.23 | Evidence | |||||
NR4A2 | ALK | RARA, NR1B1: Retinoic acid receptor alpha | 2.00 | Evidence | |||||
NR4A2 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 1.96 | Evidence | |||||
NR4A2 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 1.77 | Evidence | |||||
NR4A2 | AMPH | AMPH, AMPH1: Amphiphysin | 1.71 | Evidence | |||||
NR4A2 | PTPN7 | N/A | 1.71 | Evidence | |||||
NR4A2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 1.64 | Evidence | |||||
NR4A2 | NR1H2 | NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta | 1.62 | Evidence | |||||
NR4A2 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 1.53 | Evidence | |||||
NR4A2 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 1.53 | Evidence | |||||
NR4A2 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 1.41 | Evidence | |||||
NR4A2 | LYN | LYN: Tyrosine-protein kinase Lyn | 1.34 | Evidence | |||||
NR4A2 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 1.30 | Evidence | |||||
NR4A2 | RXRB | RXRB, NR2B2: Retinoic acid receptor RXR-beta | 1.24 | Evidence | |||||
NR4A2 | HNRPH3 | HNRPH3: Heterogeneous nuclear ribonucleoprotein H3 | 1.18 | Evidence | |||||
NR4A2 | EWSR1 | EWSR1, EWS: RNA-binding protein EWS | 1.18 | Evidence | |||||
NR4A2 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 1.17 | Evidence | |||||
NR4A2 | PTPN11 | N/A | 1.14 | Evidence | |||||
NR4A2 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 1.12 | Evidence | |||||
NR4A2 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 1.01 | Evidence | |||||
NR4A2 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 1.00 | Evidence | |||||
NR4A2 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 1.00 | Evidence |